Keyphrases
Diffuse Intrinsic Pontine Glioma
100%
Tumor
31%
Glioma Cells
28%
Medulloblastoma
25%
Diffuse Midline Glioma
22%
Pediatric
22%
Glioblastoma
21%
Pediatric Glioma
20%
High-grade Glioma
17%
Pediatric Brain Tumor
15%
Enhancer of Zeste Homolog 2 (EZH2)
15%
M-G1 Transition
12%
Autopsy
12%
Brainstem
12%
H3K27M
11%
Convection-enhanced Delivery
11%
Transcription Factor
10%
Patient-derived Xenograft
9%
Radiotherapy
9%
Restriction Point
9%
H3 K27-altered
9%
Glioma Patients
9%
Patient-derived
9%
Radiosensitization
9%
Blood-brain Barrier
9%
International Experience
8%
Temozolomide Resistance
8%
Temozolomide
8%
Agrobacterium Tumefaciens
8%
89Zr-bevacizumab
8%
CHO Cells
8%
Focused Ultrasound
8%
Tumor Cell Proliferation
8%
HEY1
8%
Prednisolone
8%
Mitogen-activated Protein Kinase
8%
Growth Factors
8%
Neurospheres
7%
Tumor Growth
7%
Clinical Trials
7%
Drug Delivery
7%
Tumor Cells
7%
Doxorubicin
7%
Histone H3
6%
Brain Tumor
6%
Drug Resistance
6%
Cell Proliferation
6%
Bevacizumab
6%
Cell Cycle Progression
6%
Targeted Therapy
6%
Medicine and Dentistry
Pontine Glioma
65%
Ganglioglioma
41%
Neoplasm
39%
Pediatrics
36%
Glioma Cell
21%
In Vitro
14%
Pediatric Brain Tumor
10%
Cytotoxicity
9%
Radiation Therapy
9%
Intracranial Tumor
8%
Biopsy Technique
8%
Malignant Neoplasm
8%
Xenograft
8%
Histone H3
8%
Glioblastoma
7%
Childhood Cancer
7%
Tumor Progression
7%
Disease
7%
Brainstem
7%
Histone
6%
Clinical Trial
5%
Cell Culture
5%
Restriction Point
5%
Drug Resistance
5%
Gene Expression
5%
Immunotherapy
5%
Personalized Medicine
5%
Endopeptidase Clp
5%